$AVXL News Article - Anavex Life Sciences Reports ANAVEX 2-73 (blarcamesine) featured as a Disease-Modifying Small Molecule in Phase 3 Clinical Trials in a New Publication in Medical Journal titled "Future Avenues for Alzheimer's Disease Detection and Therapy"
https://marketwirenews.com/news-releases/anav...16509.html